SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Daiichi Sankyo, Inc. Selects POTELLIGENT(R) CHOK1SV Cell Line for the Research, Development and Manufacture of Recombinant Antibodies